Nuvalent Inc vs Pinterest Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Pinterest Inc trades at $22.65 (market cap $12.78B). The key difference: Pinterest Inc is the larger of the two by market cap, and Nuvalent Inc is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| NUVL | PINS | |
|---|---|---|
Market Cap | $9.81B | $12.78B |
Sector | Technology | Media |
52-Week High | $123.96 | $39.17 |
52-Week Low | $72.16 | $15.42 |
Enterprise Value | $8.52B | $12.68B |
Signals from Pluang's Aura AI — not financial advice
Nuvalent (NUVL) trades at $123.96, showing no change recently, with technical indicators presenting a mixed signal—moving averages are bullish while oscillators are bearish. The company reported a net loss of $425.38 million for 2025, with negative profitability metrics like ROE of -41.19%. Recent news highlights GSK's proposed acquisition of Nuvalent for $124 per share, totaling $10.6 billion, which is under investigation by multiple law firms for fairness concerns.
The investment outlook is heavily influenced by the pending acquisition, offering a near-term exit at $124 per share. However, risks include ongoing financial losses, negative cash flow from operations, and legal scrutiny over the deal's adequacy. Analyst sentiment is mixed with 42% buy ratings, but the acquisition provides a clear valuation anchor amid fundamental challenges.
Pinterest (PINS) trades at $22.835, down 1.57% on the day, with a bullish technical outlook driven by moving averages and a consensus analyst price target of $27.53. Revenue grew to $4.22B in 2025, with net income turning positive at $416.86M, though Q2 2026 earnings are pending. Recent news highlights focus on user growth and e-commerce integration, while insider sales and cash flow trends warrant monitoring.
The stock presents upside potential from strong analyst buy ratings and revenue expansion, but risks include negative net cash flow, high valuation multiples, and competitive pressures in social media. Investor sentiment is cautiously optimistic ahead of Q2 earnings, with institutional activity showing mixed signals.
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →